PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 10110040

Quality assurance program for a nuclear pharmacy.

A Hiltz·S Pierce
View original source ↗Export metadata ↓

Abstract

The development of a quality assurance program for a nuclear pharmacy service is described. The program was established to complement and test the extensive quality control procedures in the nuclear pharmacy. Based on current nuclear pharmacy standards of practice and government regulations, audits were developed and tested for a 12-month period. Results of these audits were closely analyzed for their relevance and impact on the service. These results showed that the standards for the established quality control program were being met. It was concluded that the quality assurance program was a useful and practical tool.

Explore related subjects

Forms and Records ControlHospital Bed Capacity, 500 and overInterdepartmental RelationsNova ScotiaNuclear Medicine Department, HospitalPharmacy Service, HospitalQuality Assurance, Health CareRadioisotopesSystems AnalysisTechnology, PharmaceuticalJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A Hiltz, S Pierce. 1991. Quality assurance program for a nuclear pharmacy.. https://pubmed.ncbi.nlm.nih.gov/10110040/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2004

[Retention period for patient data: the health council of the Netherlands pleads for a change in the law].

According to the Dutch Medical Treatment Act (WGBO), patient data must be retained for at least 10 years or as much longer as required for the provision of good medical care. In practice, patient data are often destroyed after 10 years. This may lead to problems, for example if a treatment turns out to have long-term consequences. A committee of the Health Council of the Netherlands has now recommended a change in the law. They propose a longer retention period for the care of the patient, a statutory regulation governing retention for research purposes and supplementary provisions that make it possible to retain hereditary data in the interest of relatives. Until the necessary changes in the law have been made, further destruction of medical data must be prevented. This can be accomplished by revising the existing transition provision in the WGBO, while extending it by 5 years. The scientific societies can use this time to develop guidelines for the longer storage of data in specific areas of care and for the periodic cleaning up of the files.

Forms and Records Control↗